AAMC, others seek to weaken NIH proposed rule on research conflicts
Last week the Association of American Medical Colleges and three other university associations took aim at the NIH’s proposed rule to tighten disclosure and reporting requirements, departing from their initial support of tightened regs last summer.
Like t
Senate proposal would gut funding to make Americans healthier and reduce health disparities
Update: Due to response to this blog post, we would like to share additional information with those who are interested in signing-on to the letter. If you would like to sign-on, please contact Trust for America’s Health by e-mailing rhamburg@TFAH.org.
A s
Big-time savings on Rx drugs: Is the end of pay-for-delay settlements in sight?
A significant vote by the Senate Appropriations Committee last week has focused renewed attention on vital cost-saving reforms on prescription drugs that failed to make it into health reform. At issue is the drug industry practice of paying off generic co
Big-time savings on Rx drugs: Is the end of pay-for-delay settlements in sight? #2
A significant vote by the Senate Appropriations Committee last week has focused renewed attention on vital cost-saving reforms on prescription drugs that failed to make it into health reform. At issue is the drug industry practice of paying off generic co
Buyer's Blitz: Eight minutes on counterfeits
In the spirit of covering spirited drug safety hearings, we feel we ought to point out (if a little belatedly) Rep. Steve Buyer’s animated exchange on counterfeit drugs during an Energy and Commerce Health Subcommittee hearing on antibiotic resistance i
Data-mining victory: three strikes?
Earlier this month, the U.S. Court of Appeals in Boston (First Circuit) upheld Maine's 2007 data-mining law, which bans the commercial use or sale of data showing what health practitioners prescribe to their patients. Over on Health Policy Hub, Ian Reynol
Three Strikes and They're Out?
Last Wednesday patients and doctors welcomed a third win in the courts upholding state laws that limit pharmaceutical company interference with good prescribing. Judge Lynch on the U.S. Court of Appeals in Boston (First Circuit) handed down the ruling on
The Insider: The Cost of Compromise
FMAP: Victory at a Price
The Senate voted on Thursday to provide additional federal assistance to state Medicaid programs (and additional support for teachers to avoid layoffs) and the House followed suit today, but the price was high. After several attem
New Legislation to Protect and Improve the American Drug Supply
Posted today by the PostScript blog at Community Catalyst:
Posted on: August 4, 2010; 11:53 am
Yesterday, Senator Michael Bennet (D-CO) unveiled new legislation that seeks to improve the safety of America’s drug supply. The Drug Safety and Accountabi